Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1548.3000 -26.30 (-1.67%)
NSE Sep 15, 2025 15:31 PM
Volume: 759.0K
 

logo
Cipla Ltd.
07 Feb 2020
1548.30
-1.67%
ICICI Securities Limited
Revenues grew 9.1% YoY to | 4371 crore (I-direct estimate: | 4310 crore) mainly due to 12.1% YoY growth in the domestic market to | 1777 crore (Idirect estimate: | 1564.3 crore). US revenues grew 11.4% YoY to | 946 crore (I-direct estimate: | 996 crore). EBITDA margins declined 31 bps, 334 bps YoY, QoQ, respectively, to 17.3% (I-direct estimate: 20.5%) due to drop in gross margin (62.4% vs. 63.5% in Q3FY19). EBITDA grew 7.2% YoY to | 758.3 crore (I-direct estimate: | 883.5 crore). PAT grew 5.7% YoY to | 351...
Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
More from Cipla Ltd.
Recommended